Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels
- PMID: 1319114
- PMCID: PMC1682892
Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels
Abstract
The hypothesis of a genetic control of plasma angiotensin I-converting enzyme (ACE) level has been suggested both by segregation analysis and by the identification of an insertion/deletion (I/D) polymorphism of the ACE gene, a polymorphism contributing much to the variability of ACE level. To elucidate whether the I/D polymorphism was directly involved in the genetic regulation, plasma ACE activity and genotype for the I/D polymorphism were both measured in a sample of 98 healthy nuclear families. The pattern of familial correlations of ACE level was compatible with a zero correlation between spouses and equal parent-offspring and sib-sib correlations (.24 +/- .04). A segregation analysis indicated that this familial resemblance could be entirely explained by the transmission of a codominant major gene. The I/D polymorphism was associated with marked differences of ACE levels, although these differences were less pronounced than those observed in the segregation analysis. After adjustment for the polymorphism effects, the residual heritability (.280 +/- .096) was significant. Finally, a combined segregation and linkage analysis provided evidence that the major-gene effect was due to a variant of the ACE gene, in strong linkage disequilibrium with the I/D polymorphism. The marker allele I appeared always associated with the major-gene allele s characterized by lower ACE levels. The frequency of allele I was .431 +/- .025, and that of major allele s was .557 +/- .041. The major gene had codominant effects equal to 1.3 residual SDs and accounted for 44% of the total variability of ACE level, as compared with 28% for the I/D polymorphism.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis.Am J Hum Genet. 1996 Jun;58(6):1268-78. Am J Hum Genet. 1996. PMID: 8651305 Free PMC article.
-
Haplotype of growth hormone and angiotensin I-converting enzyme genes, serum angiotensin I-converting enzyme and ventricular growth: pathway inference in pharmacogenetics.Pharmacogenet Genomics. 2007 Apr;17(4):291-4. doi: 10.1097/01.fpc.0000239976.54217.ac. Pharmacogenet Genomics. 2007. PMID: 17496728
-
The angiotensin-converting enzyme (ACE) genetic polymorphism: its relationship with plasma ACE level and myocardial infarction.Clin Genet. 1994 Jul;46(1 Spec No):94-101. doi: 10.1111/j.1399-0004.1994.tb04210.x. Clin Genet. 1994. PMID: 7988087 Review.
-
Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction.Circulation. 1994 Aug;90(2):669-76. doi: 10.1161/01.cir.90.2.669. Circulation. 1994. PMID: 8044936
-
[Angiotensin-converting enzyme (ACE) polymorphism and serum ACE activities in sarcoidosis].Nihon Rinsho. 1994 Jun;52(6):1561-6. Nihon Rinsho. 1994. PMID: 8046841 Review. Japanese.
Cited by
-
The Effect of Selected Polymorphisms of the ACTN3, ACE, HIF1A and PPARA Genes on the Immediate Supercompensation Training Effect of Elite Slovak Endurance Runners and Football Players.Genes (Basel). 2022 Aug 25;13(9):1525. doi: 10.3390/genes13091525. Genes (Basel). 2022. PMID: 36140693 Free PMC article.
-
Early sign of atherosclerosis in slow coronary flow and relationship with angiotensin-converting enzyme I/D polymorphism.Heart Vessels. 2007 Jan;22(1):1-8. doi: 10.1007/s00380-006-0925-1. Epub 2007 Jan 26. Heart Vessels. 2007. PMID: 17285438
-
Genetic influences on outcome following traumatic brain injury.Neurochem Res. 2007 Apr-May;32(4-5):905-15. doi: 10.1007/s11064-006-9251-3. Epub 2007 Mar 7. Neurochem Res. 2007. PMID: 17342413 Review.
-
New molecular insights into heart failure and cardiomyopathy: potential strategies and therapies.Ir J Med Sci. 2002 Apr-Jun;171(2):99-104. doi: 10.1007/BF03168962. Ir J Med Sci. 2002. PMID: 12173899 Review.
-
Susceptibility mutations for ischemic heart disease.Curr Atheroscler Rep. 1999 Sep;1(2):108-14. doi: 10.1007/s11883-999-0006-x. Curr Atheroscler Rep. 1999. PMID: 11122699 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous